EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Prevalence of Comorbid Hyperparathyroidism and Its Association with Renal Dysfunction in Asian Patients with X-Linked Hypophosphatemic Rickets/Osteomalacia

Nobuaki Ito iD, Hee Gyung Kang, Toshimi Michigami, Noriyuki Namba, Takuo Kubota, Ayumi Shintani, Ryota Kawai iD, Daijiro Kabata, Haruka Ishii, Yayoi Nishida, Seiji Fukumoto, Keiichi Ozono

Calcified Tissue International · 12.03.2025 · 116 (1)

DOI: 10.1007/s00223-025-01359-9 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Calcified Tissue International, online erschienen am 12.03.2025. Verfasst von Nobuaki Ito und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Therapeutic Development for Intractable Bone Diseases, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, 7-3-…. Hauptthemen laut MEDLINE: Familial Hypophosphatemic Rickets, Hyperparathyroidism. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kyowa Kirin Co., Ltd., The University of Tokyo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In patients with X-linked hypophosphatemic rickets/osteomalacia (XLH) in Asia, the current prevalence of hyperparathyroidism and its association with renal dysfunction have not been determined. We used patient data retrospectively collected up to the time of informed consent in the SUNFLOWER study, a long-term observational study, to investigate the current treatment status and prevalence of comorbid hyperparathyroidism and its association with renal dysfunction in patients with XLH in Japan and South Korea. Of 69 patients who met the eligibility criteria, 32 (46.4%) did not have hyperparathyroidism (hereinafter referred to as non-hyperparathyroidism), 33 (47.8%) had secondary hyperparathyroidism, and four (5.8%) had tertiary hyperparathyroidism. Men were more prone to develop secondary and tertiary hyperparathyroidism, use oral phosphate at higher frequencies, and have a higher incidence of Stage ≥ 3 chronic kidney disease and Grade ≥ 3 renal calcification than women. Ongoing treatments for patients with XLH and non-hyperparathyroidism, secondary hyperparathyroidism, and tertiary hyperparathyroidism mainly consisted of active vitamin D (30 [93.8%], 25 [75.8%], and 3 [75.0%], respectively) and oral phosphate (21 [65.6%], 23 [69.7%], and 4 [100.0%], respectively). At informed consent, patients with tertiary hyperparathyroidism had the lowest estimated glomerular filtration rate values. Our study highlights the prevalence of comorbid hyperparathyroidism and its association with renal dysfunction in patients with XLH through a large-scale observational study in Asia. Trial registration: NCT03745521; UMIN000031605.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Familial Hypophosphatemic RicketsHyperparathyroidismHumansMaleFemalePrevalenceAdultRetrospective StudiesMiddle AgedJapanComorbidityRepublic of KoreaAsian PeopleYoung Adult

Stichwörter der Autor:innen

Chronic kidney diseaseFibroblast growth factor 23HyperparathyroidismHypophosphatemiaParathyroid hormoneX-linked hypophosphatemic rickets/osteomalacia

Autor:innen und Institutionen

  • Division of Therapeutic Development for Intractable Bone Diseases, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan. nobitotky@gmail.com.
  • Osteoporosis Center, The University of Tokyo Hospital, Tokyo, Japan. nobitotky@gmail.com.
  • Division of Pediatric Nephrology, Department of Pediatrics, Seoul National University Children's Hospital, Seoul, South Korea.
  • Department of Bone and Mineral Research, Osaka Women's and Children's Hospital, Osaka Prefectural Hospital Organization, Osaka, Japan.
  • Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, Tottori, Japan.
  • Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.

ORCID-Profile: Nobuaki Ito, Ryota Kawai

Förderung

  • Kyowa Kirin Co., Ltd.
  • The University of Tokyo

Zitieren

APA

Ito, N., Kang, H. G., Michigami, T., Namba, N., Kubota, T., Shintani, A., Kawai, R., Kabata, D., Ishii, H., Nishida, Y., Fukumoto, S., & Ozono, K. (2025). Prevalence of Comorbid Hyperparathyroidism and Its Association with Renal Dysfunction in Asian Patients with X-Linked Hypophosphatemic Rickets/Osteomalacia. Calcified Tissue International, 116(1). https://doi.org/10.1007/s00223-025-01359-9

Vancouver

Ito N, Kang HG, Michigami T, Namba N, Kubota T, Shintani A, et al. Prevalence of Comorbid Hyperparathyroidism and Its Association with Renal Dysfunction in Asian Patients with X-Linked Hypophosphatemic Rickets/Osteomalacia. Calcified Tissue International. 2025;116(1). doi:10.1007/s00223-025-01359-9

BibTeX
@article{Ito2025,
  author = {Ito, Nobuaki and Kang, Hee Gyung and Michigami, Toshimi and Namba, Noriyuki and Kubota, Takuo and Shintani, Ayumi and Kawai, Ryota and Kabata, Daijiro and Ishii, Haruka and Nishida, Yayoi and Fukumoto, Seiji and Ozono, Keiichi},
  title = {Prevalence of Comorbid Hyperparathyroidism and Its Association with Renal Dysfunction in Asian Patients with X-Linked Hypophosphatemic Rickets/Osteomalacia},
  journal = {Calcified Tissue International},
  year = {2025},
  volume = {116},
  number = {1},
  doi = {10.1007/s00223-025-01359-9}
}
Kostenlos starten →